What were the key findings of the ADapt trial, which studied patients switching to lebrikizumab after dupilumab treatment?

Featuring James Del Rosso, DO | Clinical Advisor | Adjunct Clinical Professor (Dermatology) Touro University Nevada Henderson, NV Research Director/ Principal Investigator/ Clinical Dermatologist JDR Dermatology Research Las Vegas, NV | Published October 01, 2025